Back to TCRX

GOLDMAN SACHS GROUP INC → TCRX

GOLDMAN SACHS GROUP INC TCRX Position History

TScan Therapeutics, Inc. • Healthcare

Quarters held
11
Latest value
$19K
Q3 2026
Peak value
$575K
First seen
Q2 2025

Dollar value over time

Show data table
PeriodPosition value
Q2 2025$575K
Q2 2025$48K
Q3 2025$169K
Q3 2025$69K
Q4 2025$20K
Q4 2025$67K
Q4 2025$67K
Q4 2025$20K
Q1 2026$38K
Q2 2026$69K
Q3 2026$19K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$19K59.7K——
Q2 2026$69K70.5K——
Q1 2026$38K37.3K——
Q4 2025$20K20.3K——
Q4 2025$67K66.7K——
Q4 2025$67K66.7K——
Q4 2025$20K20.3K——
Q3 2025$69K38.0K——
Q3 2025$169K93.0K——
Q2 2025$48K33.4K——
Q2 2025$575K396.7K——

Other funds holding TCRX

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B